United States (US) Biosimilars Market (2025-2031) Outlook | Revenue, Industry, Value, Trends, Growth, Companies, Share, Analysis, Size, Forecast
Market Forecast By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
| Product Code: ETC069920 | Publication Date: Jun 2021 | Updated Date: Jan 2025 | Product Type: Report | |
| Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Key Highlights of the Report:
- United States (US) Biosimilars Market Outlook
- Market Size of United States (US) Biosimilars Market, 2021
- Forecast of United States (US) Biosimilars Market, 2031
- Historical Data and Forecast of United States (US) Biosimilars Revenues & Volume for the Period 2021 - 2031
- United States (US) Biosimilars Market Trend Evolution
- United States (US) Biosimilars Market Drivers and Challenges
- United States (US) Biosimilars Price Trends
- United States (US) Biosimilars Porter's Five Forces
- United States (US) Biosimilars Industry Life Cycle
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Product for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Insulin for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Follitropin for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Calcitonin for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Glucagon for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Teriparatide for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Others for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Indication for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Oncology for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Others for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Manufacturing for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Outsourced for the Period 2021 - 2031
- Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By In-house for the Period 2021 - 2031
- United States (US) Biosimilars Import Export Trade Statistics
- Market Opportunity Assessment By Product
- Market Opportunity Assessment By Indication
- Market Opportunity Assessment By Manufacturing
- United States (US) Biosimilars Top Companies Market Share
- United States (US) Biosimilars Competitive Benchmarking By Technical and Operational Parameters
- United States (US) Biosimilars Company Profiles
- United States (US) Biosimilars Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Biosimilars Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Biosimilars Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Biosimilars Market - Industry Life Cycle |
3.4 United States (US) Biosimilars Market - Porter's Five Forces |
3.5 United States (US) Biosimilars Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 United States (US) Biosimilars Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 United States (US) Biosimilars Market Revenues & Volume Share, By Manufacturing, 2021 & 2031F |
4 United States (US) Biosimilars Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United States (US) Biosimilars Market Trends |
6 United States (US) Biosimilars Market, By Types |
6.1 United States (US) Biosimilars Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Biosimilars Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 United States (US) Biosimilars Market Revenues & Volume, By Insulin, 2018 - 2027F |
6.1.4 United States (US) Biosimilars Market Revenues & Volume, By Follitropin, 2018 - 2027F |
6.1.5 United States (US) Biosimilars Market Revenues & Volume, By Calcitonin, 2018 - 2027F |
6.1.6 United States (US) Biosimilars Market Revenues & Volume, By Glucagon, 2018 - 2027F |
6.1.7 United States (US) Biosimilars Market Revenues & Volume, By Teriparatide, 2018 - 2027F |
6.1.8 United States (US) Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 United States (US) Biosimilars Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Biosimilars Market Revenues & Volume, By Oncology, 2018 - 2027F |
6.2.3 United States (US) Biosimilars Market Revenues & Volume, By Offsite Treatment, 2018 - 2027F |
6.2.4 United States (US) Biosimilars Market Revenues & Volume, By Chronic Disorders, 2018 - 2027F |
6.2.5 United States (US) Biosimilars Market Revenues & Volume, By Blood Disorders, 2018 - 2027F |
6.2.6 United States (US) Biosimilars Market Revenues & Volume, By Infectious Diseases, 2018 - 2027F |
6.2.7 United States (US) Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F |
6.3 United States (US) Biosimilars Market, By Manufacturing |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Biosimilars Market Revenues & Volume, By Outsourced, 2018 - 2027F |
6.3.3 United States (US) Biosimilars Market Revenues & Volume, By In-house, 2018 - 2027F |
7 United States (US) Biosimilars Market Import-Export Trade Statistics |
7.1 United States (US) Biosimilars Market Export to Major Countries |
7.2 United States (US) Biosimilars Market Imports from Major Countries |
8 United States (US) Biosimilars Market Key Performance Indicators |
9 United States (US) Biosimilars Market - Opportunity Assessment |
9.1 United States (US) Biosimilars Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Biosimilars Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 United States (US) Biosimilars Market Opportunity Assessment, By Manufacturing, 2021 & 2031F |
10 United States (US) Biosimilars Market - Competitive Landscape |
10.1 United States (US) Biosimilars Market Revenue Share, By Companies, 2021 |
10.2 United States (US) Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Pricing
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Search
Related Reports
- Middle East OLED Market (2025-2031) | Outlook, Forecast, Revenue, Growth, Companies, Analysis, Industry, Share, Trends, Value & Size
- Global Hydroxychloroquine And Chloroquine Market (2025-2031) | Industry, Trends, Size, Outlook, Growth, Value, Companies, Revenue, Analysis, Share, Forecast
- Saudi Arabia Plant Maintenance Market (2025-2031) | Industry, Size, Growth, Revenue, Value, Companies, Forecast, Analysis, Share & Trends
- Taiwan Electric Truck Market (2025-2031) | Outlook, Industry, Revenue, Size, Forecast, Growth, Analysis, Share, Companies, Value & Trends
- South Korea Electric Bus Market (2025-2031) | Outlook, Industry, Companies, Analysis, Size, Revenue, Value, Forecast, Trends, Growth & Share
- Africa Low Temperature Powder Coating Market (2025-2031) | Companies, Competition, Size, Challenges, Segmentation, Trends, Competitive, Industry, Supply, Strategy, Investment Trends, Growth, Segments, Restraints, Strategic Insights, Revenue, Share, Forecast, Drivers, Analysis, Pricing Analysis, Demand, Consumer Insights, Value, Opportunities, Outlook
- North America Low Temperature Coating Market (2025-2031) | Industry, Outlook, Pricing Analysis, Forecast, Segments, Competition, Restraints, Share, Opportunities, Revenue, Challenges, Strategy, Competitive, Size, Trends, Supply, Strategic Insights, Demand, Investment Trends, Drivers, Value, Segmentation, Companies, Analysis, Consumer Insights, Growth
- North America Low Temperature Co-Fired Ceramic Market (2025-2031) | Size, Challenges, Segmentation, Pricing Analysis, Segments, Companies, Investment Trends, Share, Value, Restraints, Strategic Insights, Strategy, Analysis, Revenue, Drivers, Consumer Insights, Competitive, Trends, Industry, Growth, Demand, Opportunities, Forecast, Competition, Supply, Outlook
- North America Low Sugar Fruit Snacks Market (2025-2031) | Share, Restraints, Forecast, Competition, Size, Analysis, Investment Trends, Strategic Insights, Industry, Consumer Insights, Supply, Pricing Analysis, Outlook, Drivers, Trends, Growth, Strategy, Segmentation, Competitive, Segments, Challenges, Opportunities, Companies, Revenue, Demand, Value
- North America Low Sodium Snack Market (2025-2031) | Strategy, Supply, Challenges, Outlook, Size, Pricing Analysis, Segments, Share, Strategic Insights, Trends, Investment Trends, Segmentation, Industry, Growth, Opportunities, Value, Drivers, Consumer Insights, Demand, Forecast, Restraints, Analysis, Companies, Competitive, Revenue, Competition
Industry Events and Analyst Meet
2nd CYBER FIRST QATAR EDITION
Truck Trailer and Tyre Expo 2025
Dairy, Food and Bakery Expo 2025
Dairy and Food Expo 2025
India Green Energy Expo
Our Clients
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
6WResearch In News
- Doha a strategic location for EV manufacturing hub: IPA Qatar
- Demand for luxury TVs surging in the GCC, says Samsung
- Empowering Growth: The Thriving Journey of Bangladesh’s Cable Industry
- Demand for luxury TVs surging in the GCC, says Samsung
- Video call with a traditional healer? Once unthinkable, it’s now common in South Africa
- Intelligent Buildings To Smooth GCC’s Path To Net Zero
